Business Description
Based in Sydney, Australia, Incannex Healthcare is working to bring new treatment options to patients suffering from serious and long-term health conditions. The company is running clinical trials on several drug candidates, including treatments for sleep apnea, anxiety disorder, and a range of inflammatory conditions such as rheumatoid arthritis, asthma, and Crohn's disease. Its pipeline draws on compounds derived from or inspired by cannabis and psilocybin, developed into precise oral formulations designed to meet regulatory standards.
